SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-278075
Filing Date
2021-09-21
Accepted
2021-09-21 12:50:34
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-3 d133191df3.htm F-3 433467
2 EX-4.1 d133191dex41.htm EX-4.1 103032
3 EX-5.1 d133191dex51.htm EX-5.1 13416
4 EX-23.1 d133191dex231.htm EX-23.1 6298
5 GRAPHIC g133191dsp069.jpg GRAPHIC 2825
6 GRAPHIC g133191g0711082631486.jpg GRAPHIC 3044
7 GRAPHIC g133191g14w32.jpg GRAPHIC 33233
8 GRAPHIC g133191g57o75.jpg GRAPHIC 8942
9 GRAPHIC g133191g92r27.jpg GRAPHIC 133855
  Complete submission text file 0001193125-21-278075.txt   808465
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-259690 | Film No.: 211265751
SIC: 2836 Biological Products, (No Diagnostic Substances)